Bandingkan Harga & Kinerja Kalbe Farma Tbk (KLBF) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Kalbe Farma Tbk dan UBC Medical Indonesia Tbk.: Kalbe Farma Tbk diperdagangkan di Rp735 (kapitalisasi pasar 35,34 T, volume 24 jam 108,3 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp174 (kapitalisasi pasar 691,25 M, volume 24 jam 635,5 rb). Perbedaan utamanya: Kalbe Farma Tbk jauh lebih besar — sekitar 51,1× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Kalbe Farma Tbk lebih aktif diperdagangkan (108,3 jt vs 635,5 rb). Mana yang lebih baik tergantung tujuan investasimu.
| KLBF | LABS | |
|---|---|---|
Kapitalisasi Pasar | 35,34 T | 691,25 M |
Volume | 108,3 jt | 635,5 rb |
Lot | 1,08 jt | 6,36 rb |
Perputaran | 80,02 M | 110,15 jt |
Harga Rata-rata | 738,89 | 173,33 |
Nilai Transaksi | 80,02 M | 110,15 jt |
Harga Ekuilibrium Indikatif | 735 | 174 |
Volume Ekuilibrium Indikatif | 59,74 rb | 50 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Kalbe Farma Tbk
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Selengkapnya di halaman KLBF →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
